In fact, among over 14,500 participants across multiple studies assessing the risk of thyroid cancer incidence and the use of semaglutide (the active ingredient in GLP-1 agonists), the risk of thyroid cancer was less than 1%
This year, one of the most critical thinkers about statistics and life, Professor Scott Galloway, offered his forecast for 2024 including a major tea-leaf reading that the GLP-1 agonists would be a more impactful trend in 2024 than Gen AI would be
These services can help individuals weigh the benefits and risks of each medication, providing guidance on which may be more aligned with their specific health goals
ECL, enhanced chemiluminescence
The savings card program Eli Lilly will likely launch for retatrutide typically caps out-of-pocket costs at $25-$150 per month for commercially insured patients
Many weight loss programs separate every part of care: the first consultation, follow-up visits, medication, shipping, and monthly check-ins
